The American Journal of Medicine
Volume 119, Issue 11, Supplement 1 , Pages S25-S28 , November 2006

Case 8: Initiation of Urate-Lowering Therapy for Standard Advanced Gout

  • J. Michael Finley, DO

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to J. Michael Finley, DO, Department of Medicine, Western University–College of Osteopathic Medicine of the Pacific, 309 East Second Street, Pomona, California 91766.

References 

  1. Weiner GI, White SR, Weitzner RI, Rubinstein HM. Double-blind study of fenoprofen versus phenylbutazone in acute gouty arthritis. Arthritis Rheum. 1979;22:425–426
  2. Fam AG. Gout, diet, and the insulin resistance syndrome. J Rheumatol. 2002;29:1350–1355
  3. Shahinfar S, Simpson RL, Carides AD, et al. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia [published correction appears in Kidney Int.2000;57:370]. Kidney Int. 1999;56:1879–1885
  4. Perez-Ruiz F, Alonso-Ruiz A, Calabozo M, Herrero-Beites A, Garcia-Erauskin G, Ruiz-Lucea E. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia: a pathogenic approach to the treatment of primary chronic gout. Ann Rheum Dis. 1998;57:545–549
  5. Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity: description and guidelines for prevention in patients with renal insufficiency. Am J Med. 1984;76:47–56
  6. Becker MA, Schumacher HR, Wortmann RL, et al. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout. Arthritis Rheum. 2005;52:916–923
  7. Walter-Sack I, deVries JX, Kutschker C, Ittensohn A, Voss A. Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals. Eur J Clin Pharmacol. 1995;49:215–220
  8. Abdelrahman M, Rafi A, Ghacha R, Youmbissi JT, Qayyum T, Karkar A. Hyperuricemia and gout in renal transplant recipients. Ren Fail. 2002;24:361–367
  9. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES [National Health and Nutrition Examination Survey] I epidemiologic follow-up study, 1971-1992. JAMA. 2000;283:2404–2410

PII: S0002-9343(06)00758-3

doi: 10.1016/j.amjmed.2006.06.023

The American Journal of Medicine
Volume 119, Issue 11, Supplement 1 , Pages S25-S28 , November 2006

Article Tools

* Image Usage & Resolution